I. Zighelboim

发表

Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation Markers

Tim Hui-Ming Huang, Matthew A Powell, Pearlly S Yan, 2007, Clinical Cancer Research.

Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas.

P. Gunaratne, P. Goodfellow, C. Creighton, 2013, Cancer letters.

Cost‐Benefit of Laparoscopic Versus Medical Ovarian Suppression in Premenopausal Breast Cancer

D. Mutch, J. Rader, A. Hagemann, 2011, The breast journal.

Adjuvant treatment for early-stage endometrial cancer.

M. Powell, I. Zighelboim, 2011, Clinical obstetrics and gynecology.

Lower Uterine Segment Involvement is Associated with Poor Outcomes in Early-Stage Endometrioid Endometrial Carcinoma

F. Gao, P. Goodfellow, D. Mutch, 2011, Annals of Surgical Oncology.

The Risk of Lymph Node Metastasis With Positive Peritoneal Cytology in Endometrial Cancer

Jason D. Wright, D. Mutch, A. Hagemann, 2013, International Journal of Gynecologic Cancer.

Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement.

R. Coleman, J. Marcus, R. Harrison, 2021, Gynecologic oncology.

Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.

Jason D. Wright, D. Mutch, P. Thaker, 2013, Gynecologic oncology.

Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer

D. Mutch, P. Thaker, A. Hagemann, 2015, Gynecologic oncology reports.

The role of PET/CT in the management of patients with cervical cancer: practice patterns of the members of the Society of Gynecologic Oncologists.

P. Thaker, I. Zighelboim, A. Case, 2009, Gynecologic oncology.

HPV Vaccines: The Second Hit to Cervical Cancer

D. Mutch, I. Zighelboim, S. Geevarghese, 2006 .

Discussion: 'Perioperative morbidity model for vaginal hysterectomy' by Heisler et al.

I. Zighelboim, S. Dewdney, L. Kuroki, 2010, American journal of obstetrics and gynecology.

Gastrointestinal stromal tumor presenting as a pelvic mass.

C. Gutierrez, I. Zighelboim, C. Edwards, 2003, Gynecologic oncology.

Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.

D. Mutch, P. Thaker, M. Powell, 2011, Gynecologic oncology.

Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial.

D. Tweardy, I. Zighelboim, M. Suresh, 2005, American journal of obstetrics and gynecology.

Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome

S. Thibodeau, P. Goodfellow, A. de la Chapelle, 2009, Familial Cancer.

Lithium Chloride and Inhibition of Glycogen Synthase Kinase 3&bgr; as a Potential Therapy for Serous Ovarian Cancer

D. M. Thompson, P. Goodfellow, D. Mutch, 2012, International Journal of Gynecologic Cancer.

Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy

P. Grigsby, D. Mutch, J. Rader, 2006, Radiation Medicine.

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up

I. Zighelboim, S. Dewdney, E. Huelsmann, 2017, Gynecologic oncology reports.

The Utility and Management of Vaginal Cytology After Treatment for Endometrial Cancer

D. Mutch, P. Thaker, A. Hagemann, 2013, Obstetrics and gynecology.

Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.

P. Goodfellow, D. Mutch, M. Powell, 2007, Gynecologic oncology.

Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.

S. Thibodeau, P. Goodfellow, D. Mutch, 2008, Gynecologic oncology.

Intrapartum Epidural Analgesia and Maternal Temperature Regulation

I. Zighelboim, M. Suresh, A. Wali, 2007, Obstetrics and gynecology.

Renocolic fistula secondary to curative intent extended field radiotherapy for cervical cancer

I. Zighelboim, M. Hughes, Frank J. Tamarkin, 2018, Gynecologic oncology reports.

Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19

J. Tolosa, I. Zighelboim, A. Graul, 2022, American Journal of Obstetrics & Gynecology MFM.

Cardiac Arrest During Laparotomy With Argon Beam Coagulation of Metastatic Ovarian Cancer

J. Rader, I. Zighelboim, N. Kizer, 2009, International Journal of Gynecologic Cancer.

Do women prefer female obstetricians?

A. Tita, I. Zighelboim, 2002, Obstetrics and gynecology.

DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis

P. Goodfellow, D. Mutch, J. Rader, 2006, Modern Pathology.

The Utility of Peritoneal Biopsy and Omentectomy in the Upstaging of Apparent Early Ovarian Cancer

D. Mutch, P. Thaker, M. Powell, 2011, International Journal of Gynecologic Cancer.

Occult transitional cell carcinoma and Lynch syndrome incidentally revealed after laparoscopic hysterectomy and cystoscopy during staging for endometrial cancer.

S. Brandes, I. Zighelboim, K. Patel, 2013, Gynecologic oncology case reports.

Frequent mutations in the RPL22 gene and its clinical and functional implications.

P. Goodfellow, D. Mutch, M. Powell, 2013, Gynecologic oncology.

Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?

P. Goodfellow, D. Mutch, Katherine B. Chiappinelli, 2011, Gynecologic oncology.

Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.

P. Goodfellow, D. Mutch, J. Rader, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Search for Novel Risk Factors for Obstetric Anal Sphincter Injury

J. Stoltzfus, J. Merola, V. Lucente, 2022, Female Pelvic Medicine & Reconstructive Surgery.

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

P. Goodfellow, D. Mutch, P. Thaker, 2012, Gynecologic oncology.

DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma

P. Goodfellow, P. Thaker, F. Gao, 2011, Cancer.

The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy

P. Grigsby, J. Rader, P. Thaker, 2011, Cancer.

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.

D. Mutch, J. Rader, P. Thaker, 2010, Gynecologic oncology.

Wound complications after gynecologic cancer surgery.

D. Mutch, P. Thaker, F. Gao, 2011, Gynecologic oncology.

A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.

D. Mutch, P. Thaker, A. Hagemann, 2014, Gynecologic oncology.

High Frequency Strand Slippage Mutations in CTCF in MSI‐Positive Endometrial Cancers

Amy E. Knapp, Mingchao Xie, P. Goodfellow, 2014, Human mutation.

Retroperitoneal lymph node resection in patients with cervical cancer.

B. Slomovitz, P. Ramirez, Charlotte C. Sun, 2006, Surgical oncology.

Response to Buda et al.

P. Goodfellow, I. Zighelboim, 2008 .

Human acellular dermal matrix for closure of a contaminated gynecologic wound.

Matthew L. Anderson, C. Tung, I. Zighelboim, 2006, Gynecologic oncology.

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.

Matthew A Powell, Feng Gao, P. Goodfellow, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.

R. Broaddus, P. Ramirez, I. Zighelboim, 2004, Gynecologic oncology.

Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

K. Robison, P. Goodfellow, D. Mutch, 2015, Gynecologic oncology.

Common obstetrics and gynecologic topics in critical care: A narrative review

I. Zighelboim, Nicholas Taylor, M. Birsner, 2023, International journal of critical illness and injury science.

A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening

Dan L Crimmins, J. Gross, J. Rader, 2008, Proteomics. Clinical applications.

Acute colonic pseudoobstruction complicating twin pregnancy: a case report.

C. Tung, I. Zighelboim, M. Gardner, 2008, Journal of reproductive medicine.

Overcoming stress effects: A prospective feasibility trial of beta-blockers with upfront ovarian cancer therapy

A. Sood, L. Ramondetta, P. Thaker, 2017 .

Timing of Referral for Genetic Counseling and Genetic Testing in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

D. Jeffe, D. Mutch, P. Thaker, 2013, International Journal of Gynecologic Cancer.

Inferior vena cava filter placement in the gynecologic oncology patient: A 15-year institutional experience.

D. Mutch, S. Vedantham, N. Saad, 2011, Gynecologic oncology.

Disclosing a Diagnosis of Cancer: Considerations Specific to Gynecologic Oncology Patients

D. Jeffe, D. Mutch, P. Thaker, 2013, Obstetrics and gynecology.

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

D. Mutch, J. Rader, P. Thaker, 2010, Gynecologic oncology.

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.

B. Rimel, I. Zighelboim, S. Dewdney, 2010, Gynecologic oncology.

Intrapartum Epidural Analgesia and Maternal Temperature Regulation

I. Zighelboim, M. Suresh, A. Wali, 2007, Obstetrics and gynecology.

Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.

P. Grigsby, B. Siegel, J. Olsen, 2011, International journal of radiation oncology, biology, physics.

In vitro chemoresponse to cisplatin and outcomes in cervical cancer.

P. Grigsby, D. Mutch, J. Schwarz, 2013, Gynecologic Oncology.

"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.

Matthew A Powell, Feng Gao, D. Mutch, 2010, Gynecologic oncology.

The Role of Neoadjuvant Chemotherapy in the Management of Patients With Advanced Stage Ovarian Cancer: Survey Results From Members of the Society of Gynecologic Oncologists

B. Rimel, I. Zighelboim, S. Dewdney, 2011 .

Introductory Chapter: Teams in Healthcare - A Voyage from ‘Nice to Have’ to ‘the Way to Go’

S. Stawicki, M. Firstenberg, I. Zighelboim, 2021 .

The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer.

P. Thaker, A. Roma, M. Powell, 2011, European Journal of Gynaecological Oncology.

Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation Markers

P. Goodfellow, D. Mutch, T. Huang, 2007, Clinical Cancer Research.

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.

B. Rimel, I. Zighelboim, S. Dewdney, 2010, Gynecologic oncology.

Reproductive wastage and toxplasma antibodies.

I. Zighelboim, G. A. Maekelt, P. Maneiro, 1968, American journal of obstetrics and gynecology.

The Risk of Lymph Node Metastasis With Positive Peritoneal Cytology in Endometrial Cancer

D. Mutch, A. Hagemann, M. Powell, 2013, International Journal of Gynecologic Cancer.

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.

J. Rader, P. Thaker, I. Zighelboim, 2010, Gynecologic oncology.